127 related articles for article (PubMed ID: 12917249)
1. Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.
Becker MJ; de Marie S; Fens MH; Verbrugh HA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2003 Sep; 52(3):428-34. PubMed ID: 12917249
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
Becker MJ; de Marie S; Fens MH; Hop WC; Verbrugh HA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2002 May; 49(5):813-20. PubMed ID: 12003976
[TBL] [Abstract][Full Text] [Related]
3. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection].
Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.
Simitsopoulou M; Roilides E; Dotis J; Dalakiouridou M; Dudkova F; Andreadou E; Walsh TJ
Antimicrob Agents Chemother; 2005 Apr; 49(4):1397-403. PubMed ID: 15793118
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of high doses of liposomal amphotericin B in the treatment of experimental aspergillosis.
Martín MT; Gavaldà J; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Jordano Q; Ruiz I; Rosal M; Almirante B; Pahissa A
J Antimicrob Chemother; 2003 Dec; 52(6):1032-4. PubMed ID: 14613950
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial.
Rijnders BJ; Cornelissen JJ; Slobbe L; Becker MJ; Doorduijn JK; Hop WC; Ruijgrok EJ; Löwenberg B; Vulto A; Lugtenburg PJ; de Marie S
Clin Infect Dis; 2008 May; 46(9):1401-8. PubMed ID: 18419443
[TBL] [Abstract][Full Text] [Related]
8. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.
Ebbens FA; Georgalas C; Luiten S; van Drunen CM; Badia L; Scadding GK; Hellings PW; Jorissen M; Mullol J; Cardesin A; Bachert C; van Zele TP; Lund VJ; Fokkens WJ
Laryngoscope; 2009 Feb; 119(2):401-8. PubMed ID: 19160404
[TBL] [Abstract][Full Text] [Related]
9. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection.
Hebda PA; Piltcher OB; Swarts JD; Alper CM; Zeevi A; Doyle WJ
Laryngoscope; 2002 Sep; 112(9):1657-62. PubMed ID: 12352682
[TBL] [Abstract][Full Text] [Related]
11. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
[TBL] [Abstract][Full Text] [Related]
12. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Lyman CA; Groll AH; Mickiene D; Peter J; Bacher J; Roussillon K; Hemmings M; Armstrong D; Avila NA; Walsh TJ
Antimicrob Agents Chemother; 2004 Apr; 48(4):1188-96. PubMed ID: 15047519
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
16. Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia.
Petraitiene R; Petraitis V; Groll AH; Sein T; Piscitelli S; Candelario M; Field-Ridley A; Avila N; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2001 Mar; 45(3):857-69. PubMed ID: 11181372
[TBL] [Abstract][Full Text] [Related]
17. Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats.
Martins JO; Zanoni FL; Martins DO; Coimbra R; Krieger JE; Jancar S; Sannomiya P
Shock; 2009 Apr; 31(4):404-9. PubMed ID: 18791499
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
Ullmann AJ; Krammes E; Sommer S; Buschmann I; Jahn-Muehl B; Cacciapuoti A; Schmitt HJ
J Antimicrob Chemother; 2007 Nov; 60(5):1080-4. PubMed ID: 17855727
[TBL] [Abstract][Full Text] [Related]
20. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
Mehrad B; Strieter RM; Standiford TJ
J Immunol; 1999 Feb; 162(3):1633-40. PubMed ID: 9973423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
